CYBN

SEC filing CYBN's Helus Pharma Interim CEO to Participate in Jefferies Global Healthcare Conference Fireside Chat on June 4

16h ago

News What Makes Cybin Inc. (CYBN) a New Buy Stock

14d ago

News Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a Turnaround

14d ago

News Ouroboros Announces Leading $60M Series A Investment in Cytotheryx to Advance Cell Therapy Platform for Liver Disease

136d ago

News Arteris Closes Acquisition of Cycuity

138d ago

News Cytotheryx Secures Lead Investor for $60M Series A; Confirms Debt Financing to Expand Facilities

141d ago

News Cybin Initiates At-The-Market Equity Program of up to US$100 Million – Company Announcement

152d ago

News Cybin stock falls after launching $100 million ATM program

153d ago

News Cybin launches $100 million at-the-market equity program

153d ago

News Cybin Initiates At-The-Market Equity Program of up to US$100 Million – Company Announcement

153d ago

News Arteris to Expand Portfolio with Acquisition of Cycuity, a Leader in Semiconductor Cybersecurity Assurance

155d ago

News First Financial Secures Regulatory Approval for Acquisition of BankFinancial

168d ago